Cushman Wakefield Plc Stock Performance
| CWK Stock | USD 10.44 0.13 1.23% |
The firm shows a Beta (market volatility) of 1.58, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Cushman Wakefield will likely underperform. At this point, Cushman Wakefield plc has a negative expected return of -0.38%. Please make sure to confirm Cushman Wakefield's treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Cushman Wakefield plc performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Cushman Wakefield plc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in April 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors. ...more
Actual Historical Performance (%)
One Day Return (1.23) | Five Day Return (0.67) | Year To Date Return (17.08) | Ten Year Return (41.38) | All Time Return (41.38) |
1 | Vornado Realty to Report Q4 Earnings Whats in the Cards | 02/06/2025 |
2 | Disposition of 14789 shares by Andrew Mcdonald of Cushman Wakefield at 12.01 subject to Rule 16b-3 | 02/14/2025 |
3 | Compared to Estimates, Cushman Wakefield Q4 Earnings A Look at Key Metrics | 02/20/2025 |
4 | Disposition of 37992 shares by Michelle MacKay of Cushman Wakefield subject to Rule 16b-3 | 02/21/2025 |
5 | Disposition of 22643 shares by Michelle MacKay of Cushman Wakefield subject to Rule 16b-3 | 02/24/2025 |
6 | Disposition of 34878 shares by Andrew Mcdonald of Cushman Wakefield subject to Rule 16b-3 | 02/25/2025 |
7 | Acquisition by Andrew Mcdonald of 34878 shares of Cushman Wakefield subject to Rule 16b-3 | 02/28/2025 |
8 | Is Cushman Wakefield plc the Best UK Growth Stock to Buy Now | 03/06/2025 |
9 | Acquisition by Nathaniel Robinson of 42017 shares of Cushman Wakefield subject to Rule 16b-3 | 03/07/2025 |
10 | Office Construction Costs Ease as Inflation Slows Tariff and Labor Expenses Pose New Challenges and Uncertainties | 03/11/2025 |
11 | Why Cushman Wakefield plc Is Plunging In 2025 | 03/14/2025 |
12 | Cushman Wakefield Named to IAOP Global Outsourcing 100 List for 14th Consecutive Year | 03/17/2025 |
13 | Disposition of 5304 shares by Andrew Mcdonald of Cushman Wakefield at 10.08 subject to Rule 16b-3 | 03/18/2025 |
14 | Industry-Leading Seniors Housing Advisory Team of Josh Jandris and Brett Gardner Joins Cushman Wakefield | 03/19/2025 |
15 | HonorHealth institute opens Bioscience Core lab plus 7 more Valley deals to know | 03/20/2025 |
| Begin Period Cash Flow | 801.2 M |
Cushman |
Cushman Wakefield Relative Risk vs. Return Landscape
If you would invest 1,338 in Cushman Wakefield plc on December 24, 2024 and sell it today you would lose (294.00) from holding Cushman Wakefield plc or give up 21.97% of portfolio value over 90 days. Cushman Wakefield plc is generating negative expected returns assuming volatility of 2.3913% on return distribution over 90 days investment horizon. In other words, 21% of stocks are less volatile than Cushman, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Cushman Wakefield Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cushman Wakefield's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Cushman Wakefield plc, and traders can use it to determine the average amount a Cushman Wakefield's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1607
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CWK |
Estimated Market Risk
| 2.39 actual daily | 21 79% of assets are more volatile |
Expected Return
| -0.38 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.16 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Cushman Wakefield is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cushman Wakefield by adding Cushman Wakefield to a well-diversified portfolio.
Cushman Wakefield Fundamentals Growth
Cushman Stock prices reflect investors' perceptions of the future prospects and financial health of Cushman Wakefield, and Cushman Wakefield fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Cushman Stock performance.
| Return On Equity | 0.0765 | ||||
| Return On Asset | 0.0317 | ||||
| Profit Margin | 0.01 % | ||||
| Operating Margin | 0.07 % | ||||
| Current Valuation | 4.92 B | ||||
| Shares Outstanding | 229.73 M | ||||
| Price To Earning | 10.71 X | ||||
| Price To Book | 1.37 X | ||||
| Price To Sales | 0.25 X | ||||
| Revenue | 9.45 B | ||||
| Gross Profit | 1.73 B | ||||
| EBITDA | 614.4 M | ||||
| Net Income | 131.3 M | ||||
| Cash And Equivalents | 644.5 M | ||||
| Cash Per Share | 2.11 X | ||||
| Total Debt | 373.5 M | ||||
| Debt To Equity | 2.28 % | ||||
| Current Ratio | 1.19 X | ||||
| Book Value Per Share | 7.64 X | ||||
| Cash Flow From Operations | 208 M | ||||
| Earnings Per Share | 0.56 X | ||||
| Market Capitalization | 2.4 B | ||||
| Total Asset | 7.55 B | ||||
| Retained Earnings | (985.9 M) | ||||
| Working Capital | 360.5 M | ||||
| Current Asset | 2.37 B | ||||
| Current Liabilities | 2.07 B | ||||
About Cushman Wakefield Performance
By examining Cushman Wakefield's fundamental ratios, stakeholders can obtain critical insights into Cushman Wakefield's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Cushman Wakefield is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.03 | 0.03 | |
| Return On Capital Employed | 0.06 | 0.07 | |
| Return On Assets | 0.02 | 0.02 | |
| Return On Equity | 0.07 | 0.08 |
Things to note about Cushman Wakefield plc performance evaluation
Checking the ongoing alerts about Cushman Wakefield for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Cushman Wakefield plc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Cushman Wakefield generated a negative expected return over the last 90 days | |
| Cushman Wakefield is unlikely to experience financial distress in the next 2 years | |
| Over 99.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from bizjournals.com: HonorHealth institute opens Bioscience Core lab plus 7 more Valley deals to know |
- Analyzing Cushman Wakefield's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Cushman Wakefield's stock is overvalued or undervalued compared to its peers.
- Examining Cushman Wakefield's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Cushman Wakefield's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Cushman Wakefield's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Cushman Wakefield's stock. These opinions can provide insight into Cushman Wakefield's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cushman Wakefield plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Is Real Estate Management & Development space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cushman Wakefield. If investors know Cushman will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cushman Wakefield listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.603 | Earnings Share 0.56 | Revenue Per Share | Quarterly Revenue Growth 0.03 | Return On Assets |
The market value of Cushman Wakefield plc is measured differently than its book value, which is the value of Cushman that is recorded on the company's balance sheet. Investors also form their own opinion of Cushman Wakefield's value that differs from its market value or its book value, called intrinsic value, which is Cushman Wakefield's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cushman Wakefield's market value can be influenced by many factors that don't directly affect Cushman Wakefield's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cushman Wakefield's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cushman Wakefield is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cushman Wakefield's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.